Bristol Myers Squibb (BMY) ended the recent trading session at $56.29, demonstrating a -0.16% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain ...
In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback